Ultralife Corporation (ULBI) is a publicly traded Industrials sector company. As of September 22, 2026, ULBI trades at $5.64 with a market cap of $94.15M and a P/E ratio of -0.26. ULBI moved -1.06% today. Year to date, ULBI is -1.40%; over the trailing twelve months it is -20.11%. Its 52-week range spans $4.07 to $9.52. Rallies surfaces ULBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ULBI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.64 |
| Market Cap | $94.15M |
| P/E Ratio | -0.26 |
| EPS | $-22.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.52 |
| 52-Week Low | $4.07 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $187.24M |
| Net Income | $-6.65M |
| Gross Margin | 24.38% |
ULBI analyst coverage data. Average price target: $0.00.